MCID: ACN019
MIFTS: 32

Acanthamoeba Keratitis malady

Categories: Rare diseases, Infectious diseases

Aliases & Classifications for Acanthamoeba Keratitis

About this section
Sources:
31ICD10 via Orphanet, 40MESH via Orphanet, 48NIH Rare Diseases, 54Orphanet, 68UMLS, 69UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Acanthamoeba Keratitis:

Name: Acanthamoeba Keratitis 48 54 68

Characteristics:

Orphanet epidemiological data:

54
acanthamoeba keratitis:
Inheritance: Not applicable; Prevalence: 1-9/100000 (Europe); Age of onset: All ages; Age of death: normal life expectancy

Classifications:



External Ids:

Orphanet54 ORPHA67043
MESH via Orphanet40 D015823
ICD10 via Orphanet31 B60.1+, H19.2*
UMLS via Orphanet69 C0000880

Summaries for Acanthamoeba Keratitis

About this section
Wikipedia:71 Acanthamoeba keratitis is a rare disease in which amoebae invade the cornea of the eye. It may result in... more...

MalaCards based summary: Acanthamoeba Keratitis is related to keratitis and med13l syndrome. An important gene associated with Acanthamoeba Keratitis is APOH (Apolipoprotein H), and among its related pathways is Complement and coagulation cascades. The drug ketoconazole has been mentioned in the context of this disorder. Affiliated tissues include eye, retina and testes.

Related Diseases for Acanthamoeba Keratitis

About this section

Diseases related to Acanthamoeba Keratitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 65)
idRelated DiseaseScoreTop Affiliating Genes
1keratitis11.1
2med13l syndrome10.1APOH, F5
3vascular erectile tumor10.1APOH, F5
4lubinsky syndrome10.1APOH, F5
5supraumbilical midabdominal raphe and facial cavernous hemangiomas10.1APOH, F5
6lung cancer10.1APOH, F5
7hendra virus infection10.1APOH, F5
8hypertrichosis10.1APOH, F5
9left-right axis malformations10.1APOH, F5
10lymphocytic colitis10.1APOH, F5
11neuronopathy, distal hereditary motor, type iid10.1APOH, F5
12bullous skin disease10.1APOH, F5
13central congenital hypothyroidism10.1APOH, F5
14lynch syndrome10.1APOH, F5
15cryptosporidiosis10.1APOH, F5
16bladder hepatoid adenocarcinoma10.1APOH, F5
17czech dysplasia10.1APOH, F5
18angular blepharoconjunctivitis10.1APOH, F5
19blepharoconjunctivitis10.1APOH, F5
20intestinal disaccharidase deficiency10.1APOH, F5
21dysgammaglobulinemia10.1APOH, F5
22ophthalmia neonatorum10.1APOH, F5
23pregnancy loss, recurrent 210.0APOH, F5
24scar contracture10.0APOH, F5
25uterine corpus cancer10.0APOH, F5
26pregnancy loss, recurrent 110.0APOH, F5
27thrombophilia due to activated protein c resistance10.0APOH, F5
28spinal multifocal clear cell meningioma10.0APOH, F5
29exophthalmic ophthalmoplegia10.0APOH, F5
30immunodeficiency, common variable, 610.0APOH, F5
31sertoli-leydig cell tumor10.0APOH, F5
32leukocyte disease10.0APOH, F5
33cataract10.0
34dacryoadenitis10.0
35welander distal myopathy10.0APOH, F5
36bone development disease10.0APOH, F5
37dentine erosion10.0APOH, F5
38obstructive jaundice10.0APOH, F5
39giant papillary conjunctivitis10.0APOH, F5
40mental retardation hypotonia skin hyperpigmentation9.9F5, MBL2
41chronic tic disorder9.9APOH, F5
42herpes simplex9.9
43keratoconjunctivitis9.9
44acute proliferative glomerulonephritis9.9APOH, F5
45pericarditis9.9APOH, F5
46childhood type dermatomyositis9.9F5, MBL2
47budd-chiari syndrome9.8APOH, F5
48rectum squamous cell carcinoma9.8CXCL2, MBL2
49pulmonary hypertension9.8
50keratoconus9.8

Graphical network of the top 20 diseases related to Acanthamoeba Keratitis:



Diseases related to acanthamoeba keratitis

Symptoms & Phenotypes for Acanthamoeba Keratitis

About this section

Drugs & Therapeutics for Acanthamoeba Keratitis

About this section

Drugs for Acanthamoeba Keratitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 16)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
PseudoephedrineapprovedPhase 162890-82-47028
Synonyms:
( )-Pseudoephedrine
(+) threo-2-(methylamino)-1-phenyl-1-propanol
(+)-(1S,2S)-Pseudoephedrine
(+)-Pseudoephedrine
(+)-psi-Ephedrine
(+)-threo-Ephedrine
(1S,2S)-(+)-Pseudoephedrine
(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol
(1S,2S)-2-Methylamino-1-phenyl-1-propanol
(1S,2S)-Pseudoephedrine
(1S,2S)-Pseudoephedrine, polymer-bound
1-Ephedrine
2-(Methylamino)-1-phenyl-1-propanol
287636_ALDRICH
304-87-0
30987-59-8
37577-31-4
649031_ALDRICH
90-82-4
AC-20292
AC1L1NUA
Acunaso
Acunaso (TN)
Afrinol
BIDD:GT0817
BRD-K84175871-003-02-2
BSPBio_003261
Balminil Decongestant Syrup
Benylin Decongestant
Benzenemethanol, alpha-((1S)-1-(methylamino)ethyl)-, (alpha-S)- (9CI)
Besan
C02765
C10H15NO
CHEBI:51209
CHEMBL1590
CID7028
CPD-9954
Cenafed
D-Isoephedrine
D-Pseudoephedrine
D-Pseudoephedrine base
D-Psi-2-Methylamino-1-phenyl-1-propanol
D-Psi-Ephedrine
D08449
DB00852
Decofed
Dimetapp Decongestant
Dimetapp Decongestant Pediatric Drops
DivK1c_000451
Drixoral N.D.
Drixoral Nasal Decongestant
EINECS 202-018-6
Efidac 24 Pseudoephedrine Hcl
Efidac/24
Eltor 120
Ephedrine
Genaphed
HSDB 3177
I01-8928
IDI1_000451
Isoephedrine
KBio1_000451
 
KBio2_001358
KBio2_003926
KBio2_006494
KBio3_002762
KBioGR_001763
KBioSS_001358
L(+)-Psi-Ephedrine
L(+)-psi-Ephedrine
L-(+)-Pseudoephedrine
LS-125922
Lopac-E-3250
Maxenal
MolPort-001-684-474
Myfedrine
NCGC00015408-01
NCGC00178180-01
NCI60_002955
NINDS_000451
Neodurasina
Neodurasina (TN)
Novafed
PDSP1_001347
PSEUDOEPHEDRINE
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
Pseudoefedrina [INN-Spanish]
Pseudoephedrine
Pseudoephedrine (D)
Pseudoephedrine (INN)
Pseudoephedrine D-form
Pseudoephedrine Ephedrine
Pseudoephedrine [INN:BAN]
Pseudoephedrine d-form
Pseudoephedrinum
Pseudoephedrinum [INN-Latin]
Psi-ephedrin
Psi-ephedrine
Robidrine
SPBio_001365
STOCK1N-42675
Spectrum2_001303
Spectrum3_001771
Spectrum4_001162
Spectrum5_000650
Spectrum_000878
Sudafed
Sudafed Decongestant
Sudafed Decongestant 12 Hour
Sudafed Decongestant Extra Strength
Triaminic AM Decongestant Formula
Triaminic Infant Oral Decongestant Drops
UNII-7CUC9DDI9F
alpha-(1-(Methylamino)ethyl)benzyl alcohol
d-Isoephedrine
d-Pseudoephedrine
d-psi-2-Methylamino-1-phenyl-1-propanol
d-psi-Ephedrine
pseudoéphédrine
trans-Ephedrine
ψ-ephedrine
2
EphedrineapprovedPhase 1628299-42-39294
Synonyms:
( )-Pseudoephedrine
(+)-Ephedrin
(+)-Ephedrine
(+)-Pseudoephedrine
(+)-psi-Ephedrine
(+)-threo-Ephedrine
(+-)-Ephedrine
(-)-Ephedrine
(-)-Pseudoephedrine
(-)-psi-Ephedrine
(-)-threo-Ephedrine
(1R,2R)-Ephedrine
(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane
(1S,2R)-Ephedrine
(L)-EPHEDRINE
--EPHEDRINE
1-EPHEDRINE
1-Sedrin
134910_ALDRICH
287636_ALDRICH
287644_ALDRICH
299-42-3
304-87-0
30987-59-8
321-96-0
321-97-1
321-98-2
37577-31-4
38732-95-5
45261_FLUKA
4607-45-8
50-98-6
50906-05-3
53214-57-6
649031_ALDRICH
6912-63-6
7009-81-6
90-82-4
968-63-8
AC-20231
AC-20292
AC1L1JGK
AC1L1NUA
AC1L1RFA
AC1L1SR1
AC1L1T31
AC1L1Y3M
AC1O8JUO
AC1Q3XJE
AC1Q3XJM
AC1Q3XJN
AC1Q59F5
AC1Q7701
AI3-02761
AKOS000268842
AR-1A0126
AR-1I7143
Acunaso
Acunaso (TN)
Afrinol
Ambap299-42-3
BIDD:GT0817
BRN 3197916
BRN 4231286
BSPBio_001946
BSPBio_001968
BSPBio_003261
Benylin Decongestant
Besan
Biophedrin
C01575
C02765
C10H15NO
CHEBI:15407
CHEBI:51209
CHEMBL1590
CHEMBL211456
CHEMBL357080
CID11972440
CID5032
CID62946
CID6710657
CID7028
CID8650
CID9294
CID9457
CPD-9954
CPDD 0049
Cenafed
D00124
D08449
DB00852
DB01364
Decofed
DivK1c_000181
DivK1c_000451
DivK1c_000461
Drixoral N.D.
EINECS 202-017-0
EINECS 202-018-6
EINECS 206-080-5
EINECS 206-292-8
EINECS 206-293-3
Eciphin
Efedrin
Efidac/24
Eltor 120
Ephedral
Ephedremal
Ephedrin
Ephedrine
Ephedrine (TN)
Ephedrine (USP)
Ephedrine [USAN:BAN]
Ephedrine l-form
Ephedrital
Ephedrol
Ephedrosan
Ephedrotal
Ephedsol
Ephendronal
Ephoxamin
Fedrin
Genaphed
HSDB 3072
HSDB 3177
I-Sedrin
I01-3584
I01-8925
I01-8928
 
IDI1_000181
IDI1_000451
IDI1_000461
Isoephedrine
Jsp005664
KBio1_000181
KBio1_000451
KBio1_000461
KBio2_001358
KBio2_001500
KBio2_003926
KBio2_004068
KBio2_006494
KBio2_006636
KBio3_001188
KBio3_001446
KBio3_002762
KBioGR_001013
KBioGR_001763
KBioSS_001358
KBioSS_001500
KST-1A9168
Kratedyn
L(+)-psi-Ephedrine
L(-)-Ephedrine
L-(+)-Ephedrine
L-(-)-Ephedrine
L-Ephedrine
L-erythro-2-(Methylamino)-1-phenylpropan-1-ol
L000968
LS-125921
LS-125922
LS-43083
LS-63961
LS-63962
LS-63963
LS-63964
Lexofedrin
Lopac-E-3250
Lopac0_000501
MLS000069657
Manadrin
Mandrin
Maxenal
MolPort-001-684-474
MolPort-001-684-477
MolPort-001-684-478
MolPort-001-684-479
MolPort-001-769-085
Myfedrine
NCGC00015408-01
NCGC00015408-02
NCGC00162174-01
NCGC00178180-01
NCGC00178889-01
NCI-C55652
NCI60_002955
NINDS_000181
NINDS_000451
NINDS_000461
NSC 165609
NSC 170951
NSC 8971
NSC165609
NSC170951
NSC8971
Nasol
Neodurasina
Neodurasina (TN)
Oprea1_287330
PDSP1_000168
PDSP1_001106
PDSP1_001343
PDSP1_001345
PDSP1_001346
PDSP1_001347
PDSP2_000167
PDSP2_001090
PDSP2_001327
PDSP2_001329
PDSP2_001330
PDSP2_001331
PSEUDOEPHEDRINE
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
Pseudoephedrine (D)
Pseudoephedrinum
Psi-ephedrin
Psi-ephedrine
Robidrine
SMR000059174
SPBio_000214
SPBio_001365
SPBio_001377
ST023802
STK367993
STOCK1N-42675
Sanedrine
Spectrum2_000137
Spectrum2_001303
Spectrum2_001309
Spectrum3_000414
Spectrum3_000563
Spectrum3_001771
Spectrum4_000497
Spectrum4_001162
Spectrum5_000650
Spectrum5_000879
Spectrum5_001106
Spectrum_000878
Spectrum_001020
Sudafed
Sudafed Decongestant
UNII-03VRY66076
UNII-7CUC9DDI9F
UNII-GN83C131XS
Vencipon
WLN: QYR & Y1 & M1
WLN: QYR&Y1&M1
Zephrol
d-Ephedrine
d-Isoephedrine
d-Pseudoephedrine
d-psi-Ephedrine
l-Ephedrine
l-Pseudoephedrine
racephedrine
trans-Ephedrine
3Polyhexamethylene biguanidePhase 112
4Vasoconstrictor AgentsPhase 12122
5Respiratory System AgentsPhase 14997
6Anti-Infective AgentsPhase 122062
7TetrahydrozolinePhase 1621
8Pharmaceutical SolutionsPhase 18192
9Autonomic AgentsPhase 110150
10Peripheral Nervous System AgentsPhase 123689
11DisinfectantsPhase 1582
12Nasal DecongestantsPhase 1598
13Ophthalmic SolutionsPhase 11140
14
Tacrolimusapproved, investigational1102104987-11-3445643, 439492
Synonyms:
(-)-FK 506
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone
104987-11-3
109581-93-3 (Hydrate)
15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,
3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN
AC-1182
AC1L1K7H
AC1L97GB
AC1L9IBU
AKOS005145901
Advagraf
Ambap104987-11-3
Ambap5429
Anhydrous tacrolimus
BCBcMAP01_000194
BRD-K35452788-001-02-1
BSPBio-001279
BSPBio_001279
Bio-0921
Bio2_000470
Bio2_000950
C01375
C44H69NO10
CCRIS 7124
CHEBI:100924
CHEBI:61049
CHEMBL1200738
CID11158639
CID11556866
CID439492
CID445643
CID5372
CID5472317
CID6426916
CID6436007
CID6473866
CID6536850
CID6610362
CID6912836
CID9832283
CID9853905
CID9918805
CID9940643
CID9963169
CPD-10016
CPD000466356
D08556
DB00864
DivK1c_001040
FK 506
FK-506
FK5
FK506
FR 900506
FR-900506
 
FR900506
FT-0082660
Fk-506
Fujimycin
Graceptor
HMS1362O21
HMS1792O21
HMS1990O21
HMS2051C18
HMS2093M19
HMS503O21
IDI1_001040
IDI1_002225
K506
KBio1_001040
KBio2_000619
KBio2_003187
KBio2_005755
KBio3_001097
KBio3_001098
KBioGR_000619
KBioSS_000619
L 679934
L-679934
LCP-Tacro
LMPK04000003
LS-64247
MLS000759471
MLS001424054
Modigraf
MolPort-003-666-518
NCGC00163470-01
NCGC00163470-02
NCGC00163470-03
NCGC00163470-04
NCGC00179232-01
NChemBio.2007.16-comp1
NINDS_001040
NSC717865
Prograf
Prograf (TN)
Protopic
Protopy
S5003_Selleck
SAM001246677
SMR000466356
Tacarolimus
Tacrolimus (INN)
Tacrolimus (Prograf?)
Tacrolimus (anhydrous)
Tacrolimus anhydrous
Tacrolimus hydrate
Tacrolimus, anhydrous
Tsukubaenolide
UNII-Y5L2157C4J
nchembio.2007.23-comp2
tacrolimus
tacrolimus hydrate
15Calcineurin Inhibitors1622
16Immunosuppressive Agents13086

Interventional clinical trials:

idNameStatusNCT IDPhase
1Safety and Tolerability of Preservative-free Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Healthy SubjectsCompletedNCT02506257Phase 1
2Retrospective Study of Acanthamoebic Keratitis During the Past 10 YearsRecruitingNCT02763605
3Prospective Study of Deep Anterior Lamellar Keratoplasty Using Acellular Porcine CorneaRecruitingNCT03105466

Search NIH Clinical Center for Acanthamoeba Keratitis

Inferred drug relations via UMLS68/NDF-RT46:

Genetic Tests for Acanthamoeba Keratitis

About this section

Anatomical Context for Acanthamoeba Keratitis

About this section

MalaCards organs/tissues related to Acanthamoeba Keratitis:

36
Eye, Retina, Testes

Publications for Acanthamoeba Keratitis

About this section

Articles related to Acanthamoeba Keratitis:

(show top 50)    (show all 493)
idTitleAuthorsYear
1
Tear Cytokine Levels in Contact Lens Wearers With Acanthamoeba Keratitis. (28489721)
2017
2
Number of Bacteria and Time of Coincubation With Bacteria Required for the Development of Acanthamoeba Keratitis. (28079686)
2017
3
Acanthamoeba keratitis challenges a case report. (27220232)
2016
4
Specificity of in vivo confocal cornea microscopy in Acanthamoeba keratitis. (27312210)
2016
5
Early Deep Anterior Lamellar Keratoplasty (DALK) for Acanthamoeba Keratitis-How to Define Early? (27032028)
2016
6
Update on Acanthamoeba Keratitis: Diagnosis, Treatment, and Outcomes. (26989955)
2016
7
Strategies for the prevention of contact lens-related Acanthamoeba keratitis: a review. (26691018)
2016
8
Keratoneuritis is not pathognomonic of Acanthamoeba keratitis: a case report of Pseudomonas keratitis. (27003712)
2016
9
The Relation of Ocular Surface Irregularity and Visual Disturbance in Early Stage Acanthamoeba Keratitis. (26783979)
2016
10
Dacryoadenitis and extraocular muscle inflammation associated with contact lens-related Acanthamoeba keratitis: A case report and review of the literature. (27874294)
2016
11
Characterisation and expression analysis of trophozoite and cyst proteins of Acanthamoeba spp. isolated from Acanthamoeba keratitis (AK) patient. (27030419)
2016
12
The Impact of Topical Corticosteroids Used in Conjunction with Antiamoebic Therapy on the Outcome of Acanthamoeba Keratitis. (26952591)
2016
13
The use of dimethyl sulfoxide in contact lens disinfectants is a potential preventative strategy against contracting Acanthamoeba keratitis. (27133448)
2016
14
The Value of Cytology Smears for Acanthamoeba Keratitis. (27403362)
2016
15
Laboratory diagnosis of Acanthamoeba keratitis in Hungary. (27576919)
2016
16
Acanthamoeba Keratitis among Rigid Gas Permeable Contact Lens Wearers in the United States, 2005 through 2011. (27117780)
2016
17
Nanoemulsions Containing a Coumarin-Rich Extract from Pterocaulon balansae (Asteraceae) for the Treatment of Ocular Acanthamoeba Keratitis. (27225384)
2016
18
Painless Acanthamoeba Keratitis with Normal Vision. (27870779)
2016
19
Acanthamoeba keratitis associated with intracorneal hydrogel inlay. (26563837)
2015
20
Clinical Course of Unilateral Acanthamoeba Keratitis in a Cosmetic Contact Lens Wearer. (26116606)
2015
21
Autophagy inhibitors as a potential anti-amoebic treatment for Acanthamoeba keratitis. (25896709)
2015
22
Medical interventions for acanthamoeba keratitis. (25710134)
2015
23
Acanthamoeba keratitis: 10-Year study at a tertiary eye care center in Hong Kong. (25496910)
2015
24
Early Deep Anterior Lamellar Keratoplasty (DALK) for Acanthamoeba Keratitis Poorly Responsive to Medical Treatment. (26562819)
2015
25
Emerging Threats for Human Health in Poland: Pathogenic Isolates from Drug Resistant Acanthamoeba Keratitis Monitored in terms of Their In Vitro Dynamics and Temperature Adaptability. (26682216)
2015
26
Contact Lens-Related Acanthamoeba Keratitis and Accompanying Dacryoadenitis. (25603441)
2015
27
Regulatory Impact of Amniotic Membrane Transplantation on Presence of Adhesion/Growth-Regulatory Galectins-1 and -7 in Corneal Explants from Acanthamoeba Keratitis Patients: Clinical Note. (26338079)
2015
28
An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment. (25687209)
2015
29
Acanthamoeba keratitis: improving the Scottish diagnostic service for the rapid molecular detection of Acanthamoeba species. (25976006)
2015
30
Comparison of Fluorescence Microscopy and Different Growth Media Culture Methods for Acanthamoeba Keratitis Diagnosis. (25962772)
2015
31
IL-17A-mediated protection against Acanthamoeba keratitis. (25505284)
2015
32
Crosslinking and corneal cryotherapy in acanthamoeba keratitis - a histological study. (26483144)
2015
33
Chlorhexidine Monotherapy with Adjunctive Topical Corticosteroids for Acanthamoeba Keratitis. (26425310)
2015
34
Potential Value of Cellulose Synthesis Inhibitors Combined With PHMB in the Treatment of Acanthamoeba Keratitis. (26426333)
2015
35
The role of domestic tap water on Acanthamoeba keratitis in non-contact lens wearers and validation of laboratory methods. (26017346)
2015
36
Autofluorescence Signatures of Seven Pathogens: Preliminary in Vitro Investigations of a Potential Diagnostic for Acanthamoeba Keratitis. (26488626)
2015
37
A Rabbit Model of Acanthamoeba Keratitis That Better Reflects the Natural Human Infection. (25766300)
2015
38
Investigation of the Role of Bacteria in the Development of Acanthamoeba Keratitis. (26203748)
2015
39
Identifying differentially expressed genes in trophozoites and cysts of Acanthamoeba T4 genotype: Implications for developing new treatments for Acanthamoeba keratitis. (25543551)
2015
40
Acanthamoeba keratitis: clinical characteristics and management. (25881999)
2015
41
Genotypic characterization of amoeba isolated from Acanthamoeba keratitis in Poland. (25604673)
2015
42
Clinical characteristics of acanthamoeba keratitis infections in 28 States, 2008 to 2011. (24322804)
2014
43
Treatment of Acanthamoeba Keratitis With Intravenous Pentamidine Before Therapeutic Keratoplasty. (25255139)
2014
44
Deep anterior lamellar keratoplasty for acanthamoeba keratitis complicating the use of Boston scleral lens. (24296954)
2014
45
Development of an immunochromatographic assay kit using fluorescent silica nanoparticles for rapid diagnosis of Acanthamoeba keratitis. (25392356)
2014
46
The impact of topical corticosteroid use before diagnosis on the outcome of Acanthamoeba keratitis. (24630688)
2014
47
In vitro evaluations of topical agents to treat Acanthamoeba keratitis. (24880905)
2014
48
InA Vivo Imaging of Radial Keratoneuritis in Patients with Acanthamoeba keratitis by Anterior-Segment Optical Coherence Tomography. (24935283)
2014
49
Recommendations for the management of Acanthamoeba keratitis. (24509420)
2014
50
Therapeutic and Optical Keratoplasty in the Management of Acanthamoeba Keratitis: Risk Factors, Outcomes, and Summary of the Literature. (25262318)
2014

Variations for Acanthamoeba Keratitis

About this section

Expression for genes affiliated with Acanthamoeba Keratitis

About this section
Search GEO for disease gene expression data for Acanthamoeba Keratitis.

Pathways for genes affiliated with Acanthamoeba Keratitis

About this section

Pathways related to Acanthamoeba Keratitis according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.0F5, MBL2

GO Terms for genes affiliated with Acanthamoeba Keratitis

About this section

Cellular components related to Acanthamoeba Keratitis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular regionGO:00055768.7APOH, CXCL2, F5, MBL2
2extracellular spaceGO:00056158.0APOH, CXCL2, F5, MBL2

Biological processes related to Acanthamoeba Keratitis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1platelet degranulationGO:00025769.3APOH, F5

Molecular functions related to Acanthamoeba Keratitis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1serine-type endopeptidase activityGO:00042529.0F5, MBL2

Sources for Acanthamoeba Keratitis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet